[Federal Register Volume 76, Number 181 (Monday, September 19, 2011)]
[Notices]
[Page 58025]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-24005]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung and Blood Institute Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Gene Therapy Resource Program LentiVirus
Vector Production.
Date: October 7, 2011.
Time: 8:30 a.m. to 10 a.m.
Agenda: To review and evaluate contract proposals.
Plae: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda MD 20814.
Contact Person: Tony L Creazzo, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892-7924,
301-435-0725, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Gene Therapy Resource Program Pharmacology/
Toxicology Core.
Date: October 7, 2011.
Time: 10 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract proposals.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892-7924,
301-435-0725, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Gene Therapy Resource Program PreClinical
Vector Production Core.
Date: October 7, 2011.
Time: 11:30 a.m. to 1 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892-7924,
301-435-0725, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Gene Therapy Resource Program Adeno-
Associated Virus Vector Production Core.
Date: October 7, 2011.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892-7924,
301-435-0725, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Gene Therapy Resource Program Clinical
Coordinating Center.
Date: October 7, 2011.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892-7924,
301-435-0725, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-24005 Filed 9-16-11; 8:45 am]
BILLING CODE 4140-01-P